Press Releases

Featured Press Releases

BIO Statement Regarding Nomination of Robert F…

BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…

Learn more

BIO Released the Following Statement After…

“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…

Learn more

BIO Statement on Lawsuit Over 340B Rebates

BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…

Learn more

BIO Statement on Proposed Changes to Medicare Advantage and Part D Plans

November 26, 2018

“Today’s proposed rule to roll back critical protections afforded to some of America’s sickest and most vulnerable Medicare beneficiaries would, if adopted, severely limit seniors’ access to the drugs most appropriate for them, and is yet another…

New Report Shows Global Link Between Pro-Innovation Policies and Biotech Advances

November 19, 2018

Washington, D.C. (November 19, 2018) – A study released today highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world.The fifth edition…

BIO Releases Third Report in a Series on the State of Innovation in Highly Prevalent Chronic Diseases

November 15, 2018

Washington, DC (October 26, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases: Volume III Type 2 Diabetes and Obesity Therapeutics, the third in a…

BIO Applauds International Support of Agricultural Applications of Precision Biotechnology

November 5, 2018

The following statement may be attributed to Joseph Damond, Executive Vice President, International Affairs for the Biotechnology Innovation Organization, in response to the United States and 12 other nations signing on to the International…

BIO Welcomes Announcement of FDA’s Plant and Animal Biotechnology Innovation Action Plan

November 1, 2018

Washington, D.C. (November 1, 2018) – The Biotechnology Innovation Organization (BIO) released the following statement regarding the U.S. Food and Drug Administration (FDA) Plant and Animal Biotechnology Innovation Action Plan:

BIO Statement on the Administration’s Drug Pricing Proposal

October 25, 2018

Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood issued the following statement after the Trump administration outlined proposed changes to the Medicare Part B program.

BIO Applauds President Trump's Directive to Allow Sales of E15 Fuel Year-Round

October 9, 2018

The following statement may be attributed to Brent Erickson, BIO’s Executive Vice President, Industrial and Environmental Section, in response to President Donald Trump’s directive allowing the sale of E15 fuels year-round.

BIO Statement on the United States-Mexico-Canada Agreement

October 4, 2018

Washington, D.C. (October 4, 2018) – Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):“BIO supports the USMCA and appreciates…

BIO Joins Alliance to Protect Medical Innovation

October 4, 2018

"Innovation and bad public policy cannot coexist. That’s an important message often neglected in the debate about health care costs, and that’s precisely the message this organization will help deliver.”

BIO Applauds House Passage of the American Innovation Act

September 27, 2018

Bill reforms tax rules that currently penalize investment in job creation, innovation Washington, DC (September 27, 2018) – The Biotechnology Innovation Organization (BIO) today applauded the House of Representatives for passing the…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.